Document is current
Any future updates will be listed below
-
Authors
Van Spall, Harriette G. C. https://orcid.org/0000-0002-8370-4569
Vardeny, Orly
-
Funding
Funding for this research was provided by:
Bayer AG
- License Information
-
More Information
Article History
Received: 6 March 2026
Revised: 16 April 2026
Accepted: 17 April 2026
First Online: 26 May 2026
Declarations
:
: Dr Van Spall receives funding from the Canadian Institutes of Health Research and has served on clinical trial committees sponsored by Medtronic, Novo Nordisk, Pfizer, the CardioVascular Research Foundation, and Colorado Prevention Center Clinical Research, and has received education or research funding from Bayer, Boehringer Ingleheim, and Novartis outside the submitted work. Dr Vardeny reports grants from AstraZeneca and Cardior as well as institutional research support from Bayer and Cardurion outside the submitted work.
